Aktiia, the global leader in continuous blood pressure monitoring, today announced that it is bringing its 24/7 Blood Pressure Monitor to the United States, delivering the next generation of clinical wearables specifically designed to meet the needs of both patients and physicians.

Aktiia’s Optical Blood Pressure Monitoring (OBPM®) algorithms leverage optical sensors worn on the wrist and provide blood pressure values using Photoplethysmography (PPG) to analyze the changing diameter of the arteries occurring at each heartbeat. This optical measurement is done automatically, so users are not aware and stressed, and do not have to interrupt their day or their sleep to take a measurement.

Related Biobeat Launches Wearable Continuous Ambulatory Blood Pressure Monitoring Device

Aktiia’s 24/7 blood pressure monitor automatically gathers over 100x the data and has over 10x the engagement of other blood pressure monitors.  The wearable’s wrist-based optical sensor measures around the clock, providing data that can be instantly viewed in a mobile app and easily shared with a physician or family member.

In the United States, nearly 50% of adults, about 116 million people, have high blood pressure. Of these, up to 75% do not have their blood pressure under control. This ongoing hypertension epidemic is the number one cause of major cardiovascular events like heart attack and stroke, and leads to more than half a million unnecessary deaths every year in the US alone, according to a press release.

Recent large-scale studies have demonstrated that the more consistently a patient stay in their target blood pressure range, the lower their risk of heart attack and strokes.

Aktiia’s solution improves patient engagement, with current users checking their blood pressure on average 15 to 20 times per week, versus 1 to 2 times with traditional blood pressure cuffs.

Aktiia’s co-founders spent 17 years developing its game-changing technology, which has since been validated in multiple clinical studies. In addition to endorsement by leading experts in hypertension management, Aktiia is now also an official partner of the International Society of Hypertension and the World Heart Foundation.

Aktiia is coming to the United States via a landmark study with Brigham and Women’s Hospital (BWH), a top 10 hospital for cardiology with one of the world’s most innovative hypertension clinics. Aktiia is sponsoring the COOL-BP (Continual vs. Occasional Long-Term BP) study within the Remote Hypertension Program, to be conducted by Dr. Naomi Fisher, Associate Professor of Medicine at Harvard Medical School and Director of BWH’s Hypertension Service, and a consultant and advisor to Aktiia.

Dr. Fisher states: “Hypertension affects nearly half of Americans, every hour of every day.  Yet current measurement devices only capture a brief snapshot of overall blood pressure, and they are burdensome to use.  The COOL-BP study will test an optical cuffless technology in BWH’s remote hypertension management program.  An innovation that automatically provides blood pressure readings continually through days and nights holds tremendous promise in our efforts to control hypertension, both for individuals and for global health.”

CES Availability

In addition to the study at BWH, Aktiia also will be available for introduction and demonstration at CES 2022 at ShowStoppers January 5 from 6 – 10 pm in Las Vegas.

Related Apple Reportedly Looking to Add Blood Pressure Monitoring and Fertility Tracking In Smartwatch

About Aktiia

Aktiia was founded in Switzerland in May 2018. The startup has some of the world’s leading scientific and technical experts in optical blood pressure monitoring. The core technology was first developed over decades of research at the prestigious Swiss Center for Electronics and Microtechnology (CSEM), under a team lead by Aktiia co-founders, Dr. Mattia Bertschi and Dr. Josep Sola. In late 2021, Aktiia raised a $17.5M Series A round of funding, led by UK-based venture capital firm Molten Ventures (formerly Draper Esprit).

Our Gadget of the Month empowers you to live your life to the full: The CART manufactured by Skylabs!

Field of Application

CART is a ring-type medical device that continuously monitors your heart health using photoplethysmography and electrocardiogram signals.

Unique features of CART include:

• Continuous heart monitoring
• Atrial Fibrillation detection with 99.6% Accuracy
• Real-time measurements and analysis
• Remote data access from your doctor
• Simplicity and ease of use

The heart rate is measured continuously and the ECG measurement can be triggered at will.

Technological Background

An irregular pulse wave is measured automatically by monitoring the blood flow in the finger through the optical sensor. Monitored data is sent to the cloud to detect and analyze atrial fibrillation using Artificial Intelligence. The results are sent to the companion user app and physician platform. The CART system combines photoplethysmography (PPG) to measure heart rate (HR) and detect atrial fibrillation. The electrocardiogram (ECG) measurements which are triggered at will provide the doctor with additional information.

This unique combination of sensor technologies packed into the small form factor of a ring makes the CART our Innovation of the Month! If you would like to learn more about CART, you are lucky: Skylabs is partnering with WT | Wearable Technologies again at the WT | Show at MEDICA 2022! Come and visit us and get introduced to Skylabs!

Want to learn more about Skylabs directly? Visit their Website: https://skylabs.io/

Penn State researchers have developed a wearable glucose monitor that can non-invasively measure glucose levels within sweat in real time.

Noninvasive glucose monitoring devices are not currently commercially available in the United States, so people with diabetes must collect blood samples or use sensors embedded under the skin to measure their blood sugar levels. Now, with a new wearable device created by Penn State researchers, less intrusive glucose monitoring could become the norm.

Read more Know Labs Introduces KnowU, A Portable Medical-Grade Glucose Monitoring Device That Utilizes Bio-RFID

Led by Huanyu “Larry” Cheng, Dorothy Quiggle Career Development Professor in Penn State’s Department of Engineering Science and Mechanics, the researchers published the details of the noninvasive, low-cost sensor that can detect glucose in sweat in Biosensors and Bioelectronics. The paper, available online, will publish in the journal’s December print issue.

The researchers constructed the device first with laser-induced graphene (LIG), a material consisting of atom-thick carbon layers in various shapes. With high electrical conductivity and a convenient fabrication time of just seconds, LIG appeared to be an ideal framework for the sensing device — but there was a significant caveat, writes Gabrielle Stewart at PSU website.

“The challenge here is that LIG is not sensitive to glucose at all,” Cheng said. “So, we needed to deposit a glucose-sensitive material onto the LIG.”

The team chose nickel because of its robust glucose sensitivity, according to Cheng, and combined it with gold to lower potential risks of an allergic reaction.

The nickel-gold alloy’s sensitivity allowed Cheng’s team to exclude enzymes, which are often used to measure glucose in more invasive, commercially available devices or in noninvasive monitors proposed by other researchers. These enzymes, however, can degrade quickly with time and changing temperatures.

“An enzymatic sensor has to be kept at a certain temperature and pH, and the enzyme can’t be stored in the long term,” Cheng said. “A nonenzymatic glucose sensor, on the other hand, is advantageous in terms of stable performance and glucose sensitivity regardless of these changes.”

Nonenzymatic sensors require alkaline solution, which can damage the skin and typically limits device wearability. To curb this issue, Cheng and his team attached a microfluidic chamber to the LIG alloy.

With a smaller alkaline solution chamber, the entire device is roughly the size of a quarter and is flexible enough to maintain a secure attachment to the human body, Cheng said.

In a proof-of-concept test, the researchers used a skin-safe adhesive to attach the reusable device to a person’s arm one hour and three hours after a meal. The subject performed a brief workout — just enough to produce sweat — right before each measurement time. A few minutes after collecting the sweat, the researchers found that the detected glucose concentration dropped from the first measurement to the next. The glucose measurements from the device were verified by measurements made with a commercially available glucose monitor.

Cheng and the team plan to improve upon their prototype for future applications, including addressing how patients or clinicians may use the sensor for incremental glucose measurements or continuous monitoring to determine treatment actions, such as administering insulin. They also intend to refine and expand this platform for more comfortable monitoring of other biomarkers that can be found in the sweat or interstitial fluids that fill the space between cells in the body.

Read more New Trend In Medical Wearables Is Continuous Glucose Monitoring

“We want to work with physicians and other health care providers to see how we can apply this technology for daily monitoring of a patient,” Cheng said. “This glucose sensor serves as a foundational example to show that we can improve the detection of biomarkers in sweat at extremely low concentrations.”

The healthcare industry is currently experiencing seismic shifts with much of the focus being placed on COVID-19 clinical, operational, and financial efforts. In 2021, E-Commerce giant Amazon expanded its healthcare aspirations with Alexa, Amazon Care, COVID-19 tests and more.

Amazon Care

Amazon first introduced its healthcare clinics to its employees in early 2019 after providing them with virtual care services. Its virtual care app, Amazon Care, lets people connect with physicians online through messages and video, with an option for an in-person visit from a nurse for exams, tests, and vaccines.

Related Amazon’s Halo Fitness Tracker Will Soon Be Able To Judge Your Movement Health By Using Your Smartphone Camera

Currently, Amazon in 2022 will add 16 additional cities including Atlanta; Denver; Detroit; Houston; Indianapolis; Kansas City, Missouri; Los Angeles; Miami; Minneapolis; Nashville, Tennessee; New York; Phoenix; Pittsburgh; San Francisco; San Jose, California; and St. Louis.

The healthcare industry is currently experiencing seismic shifts with much of the focus being placed on COVID-19 clinical, operational, and financial efforts. However, even in the setting of the pandemic, the healthcare industry is still faced with addressing a growing aging population, a widening workforce gap, and a proliferating volume of healthcare data.

Alexa Together

Amazon’s Alexa voice assistant is now making moves into health systems and elder care. In September, the company announced Alexa Together, a subscription service that allows caregivers to remotely monitor and assist aging family members in their homes. They receive alerts if their loved one hasn’t used Alexa by a certain time. Caregivers can also remotely set reminders or help their family members manage settings on their devices, reports MobiHealthNews.

AWS Healthcare Accelerator

In a blog post, Sandy Carter, Vice President at AWS, announced the launch of the “Amazon Web Services (AWS) Healthcare Accelerator program,” which is “ a four-week technical, business, and mentorship accelerator opportunity open to U.S.-based healthcare startups or international healthcare startups that have existing U.S. operations.”

“The goal of the AWS Healthcare Accelerator is to cultivate and promote innovative startup solutions that achieve the Quadruple Aim of improved patient experience, improved clinician experience, better health outcomes, and lower cost of care. In seeking out compliant data-driven healthcare solutions, AWS will support public sector healthcare enterprises to accelerate their digital transformation,” said Carter.

Related Vayyar Partners With Amazon To Provide Touchless Fall Detection Solution

COVID-19 Test

In July, 2021, Amazon announced its at-home COVID-19 test kit is now available to U.S. customers.

The U.S. Food and Drug Administration granted an Emergency Use Authorization to the Amazon COVID-19 Test Collection Kit DTC earlier last year, paving the way for its broader use.

“Even as COVID-19 vaccinations continue, widespread access to reliable and affordable COVID-19 testing remains a critical tool in the fight against the spread of the virus,” said Amazon Vice President Cem Sibay in a statement.

Researchers at Nanyang Technological University, Singapore (NTU Singapore) have developed a thin and flexible paper battery that could one day become an environmentally sustainable option for powering flexible and wearable electronic systems.

The NTU Singapore-developed zinc batteries are made up of electrodes (through which the electrical current leaves or enters the battery) screen-printed onto both sides of a piece of cellulose paper that has been reinforced with hydrogel.

Read more: UBC Researchers Develop Stretchy, Washable Batteries for Medical Wearables

Once the battery has been expended, it can be buried in soil, where it breaks down completely within a month.

In a proof-of-concept experiment described in the scientific journal Advanced Science, the NTU team demonstrated how a 4cm x 4cm square printed paper battery could power a small electric fan for at least 45 minutes. Bending or twisting the battery did not interrupt the power supply.

In another experiment using a 4cm x 4cm battery to power an LED, the scientists showed that despite cutting away parts of the paper battery, the LED remained lit, indicating that cutting does not affect the functionality of the battery.

The scientists think their printed battery could be integrated into flexible electronics such as foldable smartphones that are already on the market, or biomedical sensors for health monitoring.

Professor Fan Hongjin from the NTU School of Physical and Mathematical Sciences and the study’s co-lead author, said: “Traditional batteries come in a variety of models and sizes, and choosing the right type for your device could be a cumbersome process. Through our study, we showed a simpler, cheaper way of manufacturing batteries, by developing a single large piece of battery that can be cut to desired shapes and sizes without loss of efficiency. These features make our paper batteries ideal for integration in the sorts of flexible electronics that are gradually being developed.”

Assistant Professor Lee Seok Woo from the NTU School of Electrical and Electronic Engineering and the study’s co-lead author, said: “We believe the paper battery we have developed could potentially help with the electronic waste problem, given that our printed paper battery is non-toxic and does not require aluminum or plastic casings to encapsulate the battery components. Avoiding the packaging layers also enables our battery to store a higher amount of energy, and thus power, within a smaller system.”

An eco-friendly alternative

With hydrogel and cellulose are naturally broken down by bacteria, fungi, and other microorganisms, the battery can simply be buried in soil at the end of its life span where it breaks down in a matter of weeks, making it a fully biodegradable product.

Read more: Stretchable System Can Power Wearables By Harvesting Energy From Wearer’s Breathing and Motion

To demonstrate the paper battery’s biodegradability, the NTU scientists buried it in the soil of a rooftop garden on the NTU campus. The hydrogel-reinforced cellulose paper started fracturing after two weeks and degraded completely within a month.

Prof Fan said: “When decomposition happens, the electrode materials are released into the environment. The nickel or manganese used in the cathodes will remain in their oxide or hydroxide forms, which are close to the form of natural minerals. The zinc found in the anode will be naturally oxidized to form a non-toxic hydroxide. This points to the battery’s potential as a more sustainable alternative to current batteries.”

The NTU team hopes to demonstrate the complete integration of the printed paper battery into other printed electronics, electronic skins, as well as energy storage systems deployed in the environment.

Researchers at the University of British Columbia have created a flexible waterproof battery that is durable enough to undergo multiple wash cycles. The battery is so pliant that it works even when twisted or stretched to twice its normal length, or after being tossed in the laundry.

Read more: Swiss Researchers Develop Stretchable Batteries for Wearable and Foldable Devices

“Wearable electronics are a big market and stretchable batteries are essential to their development,” says Dr. Ngoc Tan Nguyen, a postdoctoral fellow at UBC’s faculty of applied science. “However, up until now, stretchable batteries have not been washable. This is a critical addition if they are to withstand the demands of everyday use.”

The battery developed by Dr. Nguyen and his colleagues offers a number of engineering advances. In normal batteries, the internal layers are hard materials encased in a rigid exterior. The UBC team made the key compounds—in this case, zinc and manganese dioxide—stretchable by grinding them into small pieces and then embedding them in rubbery plastic, or polymer. The battery comprises several ultra-thin layers of these polymers wrapped inside a casing of the same polymer. This construction creates an airtight, waterproof seal that ensures the integrity of the battery through repeated use.

It was team member Bahar Iranpour, a Ph.D. student, who suggested throwing the battery in the wash to test its seal. So far, the battery has withstood 39 wash cycles and the team expects to further improve its durability as they continue to develop the technology, reports UBC.

“We put our prototypes through an actual laundry cycle in both home and commercial-grade washing machines. They came out intact and functional and that’s how we know this battery is truly resilient,” says Iranpour.

The choice of zinc and manganese dioxide chemistry also confers another important advantage. “We went with zinc-manganese because for devices worn next to the skin, it’s a safer chemistry than lithium-ion batteries, which can produce toxic compounds when they break,” says Nguyen.

An affordable option

Work is underway to increase the battery’s power output and cycle life, but already the innovation has attracted commercial interest. The researchers believe that when the new battery is ready for consumers, it could cost the same as an ordinary rechargeable battery.

“The materials used are incredibly low-cost, so if this is made in large numbers, it will be cheap,” says electrical and computer engineering professor Dr. John Madden, director of UBC’s Advanced Materials and Process Engineering Lab who supervised the work. In addition to watches and patches for measuring vital signs, the battery might also be integrated with clothing that can actively change color or temperature.

Read more: Thin-Film, Flexible and Printed Batteries Market Will Grow To $500 Million in 2030, Says IDTechEx

“Wearable devices need power. By creating a cell that is soft, stretchable, and washable, we are making wearable power comfortable and convenient.” The battery is described in a new paper published recently in Advanced Energy Materials.

Chinese tech giant Huawei is reportedly planning to release its first true smart glasses 'Huawei Smart Glass' on December 23 in China. Alongside this, the company will also debut the Huawei P50 Pocket folding phone, Blood Pressure Watch D, and more products.

Read more: Not Getting A Good Night’s Sleep? Huawei Wearables Will Help You Understand Your Sleep Cycle

This announcement comes in piping hot right after Oppo announced its first Oppo Air Glass at its Oppo INNO Day 2021 event on 14 December 2021. The glass features futuristic styling with a single-lens design and weighs less than 30 grams. The Air Glass is also designed to snap onto custom frames offered by OPPO using magnetic components housed inside the Air Glass frame.

Huawei has released the first introduction video of upcoming smart glasses that support lens replacement and the side of the frame equipped with a sound system. In addition, it supports the HarmonyOS system.

Earlier, Huawei released two glasses under its name, however, both were in collaboration with spectacles maker Gentle Monster. The upcoming Huawei Smart Glass does not feature any collaboration branding. According to the official warm-up video, Huawei smart glasses support lens replacement, and the left and right glasses frames are equipped with sound units. Huawei named the new product “Huawei Smart Glasses”, and there is no glasses brand logo, and it may be a brand new product series.

Read more: Huawei Launching Two New Wearables In Austria Will Open Experience Store In Vienna

The curved earpiece angle on the new smart glass has been increased from the first generation, from 12 degrees to 20 degrees, to achieve a better fit. It supports updated smart gesture control. For pairing, users only need to gently pinch on the left temple, reports HuaweiCentral.

In addition, it offers a wider soundstage range for a more immersive sound experience, perfect for listening to music, playing games, or watching TV, and much more.

The Metaverse has been a hot topic of conversation recently, with Facebook and Microsoft both staking claims. But what is the Metaverse? And when will it get here?

The Metaverse is a hypothesized iteration of the Internet, supporting persistent online 3-D virtual environments through conventional personal computing, as well as virtual and augmented reality headsets. Aspects of the Metaverse have already been implemented in virtual world platforms such as Second Life. Some iterations of the Metaverse involve integration between virtual and physical spaces and virtual economies.

Read more: MetaEstate Officially Promulgated Integrated Planning of Satoshi Island in Cryptovoxels Metaverse

Current Metaverse development is centered on addressing the technological limitations of virtual and augmented reality devices. However, without wearable technology to bridge between the material and virtual worlds, the Metaverse will be little more than a pipedream, reports T_HQ.

Qualcomm’s CEO Cristiano Amon says "smart glasses could eventually be as widespread as smartphones."

“For all of the devices that are being commercially deployed, you have one thing in all of them — which is Snapdragon XR,” Amon told Yahoo Finance Live, referencing Qualcomm’s extended reality version of its main Snapdragon platform. “So we’re very excited about that opportunity, and it could be as big as phones if you have companion glasses that you carry together with your smartphone.”

The VR experience is not complete without Metaverse. For example, in the movie Ready Player One, the focus was on players completing quests in the Oasis. Players had to wear sensor suits in order to enjoy the complete experience in the Oasis. These suits reflect the virtual surroundings of the Metaverse.

Niantic is the company behind Pokémon Go and other augmented reality apps. The company is currently developing AR glasses.

Read more: Facebook’s New Wrist-Based Wearable Lets You Interact With Augmented Reality

Niantic’s CEO John Hanke said, "Think about a wearable device, with you all day long, on your head. It probably knows where you are looking most of the time. Maybe it knows other things, like your heart rate. If you see an advertisement, did your heart rate go up? When you see a person [it identifies], what did your heart rate do? Did your pupils dilate? What about your emotions? Are you happy, sad, anxious?"

"This is not science fiction," he continued. "Tech can do what I described. Whether we allow that to evolve into the dystopia that we all know it could be, or take steps to turn it into something else, is a collective job for all of us."

The sports technology market size is expected to grow by USD 24.56 bn from 2021 to 2026. The market is expected to record a year-over-year growth rate of 21.48% in 2022.

The sports technology market has been segmented by technology into three segments, namely AI ML, IoT, and AR VR. By technology, the AI ML segment will have significant market share growth during the forecast period. AI can perform automated tasks, assist in performing tasks efficiently and quickly, help with better decision-making, and automate decision-making processes.

Read more: WHOOP Acquires Sports Tech Startup PUSH To Unlock Deeper Strength-Training Insights

Some of the primary growth drivers for the sports technology market are the rising number of sports technology events, the launch of new platforms, and growing participation in sports tournaments, according to a senior analyst at Technavio. The market forecast reports by Technavio help organizations make confident business decisions with the help of thorough research and expert analysis, says a press release.

Vendor Offerings

• Agile Sports Technologies Inc. - The company offers Volleymetrics that can record and upload analytics with automatic smart cameras and saves time.
• Athlete Intelligence - The company offers VECTOR MouthGuard which is a highly accurate head impact monitoring wearable device for team contact sports.
• Catapult Group International Ltd. - The company offers wearable technology such as Catapult Vision which brings pre- and post-match analysis and Catapult AMS which elevates the management and communication of data.
• Chetu Inc. - The company offers sports analytics and athlete performance solutions that build a suite of sports analytics tools designed for ultimate performance intelligence.
• Cisco Systems Inc. - The company offers sports technology such as Esports.

Regional Analysis

• Based on geography, the sports technology market has been segmented into five regions, namely North America, Europe, APAC, South America, and MEA.
• 43% of the growth is expected to originate from North America.
• The US and Canada are the key countries for the sports technology market in North America.
• Market growth in this region will be faster than the growth of the market in North America, Europe, APAC, South America, and MEA.
• The launch of innovative and improved sports technology products and platforms, growing Internet penetration, and the launch of advanced video game consoles will drive the growth of the sports technology market in North America during the forecast period.

Notes:

• The sports technology market size is expected to accelerate at a CAGR of 23.09% during the forecast period.
• The market is fragmented due to the presence of many vendors holding significant market shares.
• The research report offers information on several market vendors, including Agile Sports Technologies Inc., Athlete Intelligence, Catapult Group International Ltd., Chetu Inc., Cisco Systems Inc., Epicor Software Corp., Firstbeat Technologies Oy, International Business Machines Corp., Jonas Club Software, and SAP SE.

Read more: Tokyo Olympics: Indian Olympic Association acquires Dhyana Rings For Its Athletes To Improve Mental Wellness

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Hapbee Technologies, the smart wearable, wellness technology company today announced three special holiday-themed blends that can be enjoyed through the Hapbee smart wearable device and app.

Grounded in science, the Hapbee Smart Wearable is designed to help people find calm, improve focus, sleep, and performance. The new blends were designed with the holidays in mind – time for recuperation, festive gatherings, and family get-togethers.

Read more: Hapbee Launches New “Boost” Signal To Provide Users With Caffeine-Free Energy Boost

"Getting into the holiday spirit can be a struggle for some and Hapbee is there to lend a helping hand – without the unwanted side effects of ingesting a stimulant," said Yona Shtern, CEO of Hapbee. "Hapbee helps people control how they want to feel, sleep, create and play. A series of Holiday Blends seemed like the perfect gift to offer to our community of subscribers combined with our smart wearable innovation."

Hapbee subscribers will now be able to choose from a total of 22 signature lifestyle blends and will automatically receive the new holiday blends when they update the Hapbee App to the latest release – free for download from the App Store and Google Play, the company said in a press release.

Overview of New Holiday Blends:

• Winter's Nap: An engineered blend derived from digital Melatonin and CBD.
• Set the timer for 30 minutes for a cat nap between chores or for 2 hours for a power snooze before the big game or an outing with friends.
• Oh Joy: An engineered blend derived from digital caffeine and alcohol

• Ring in the holiday season with a digital boost of fun and frolic. No need to open a bottle to feel the warm rush of merriment. Just dial into this fun blend combining some of your favorite "refreshers" without any of the side effects.
• Family Time: An engineered blend derived from digital CBD and alcohol
• Climb into the right state of relaxation that will make hours with family (especially in-laws) melt away. Blended to help you take the edge off and ensure this holiday season is the chilliest one yet.

Read more: Nano membrane Wearable Sensors Deliver Precision and Continuous Stress Monitoring

About Hapbee

Hapbee is an innovative wearable wellness technology company that helps people enhance how they feel. Powered by patented ultra-low radio frequency energy (ulRFE) technology, Hapbee delivers low-power electromagnetic lifestyle blends designed to produce sensations such as Happy, Alert, Focus, Relax, and others. The Company has offices in Montreal, Vancouver, Seattle, and Phoenix.

Medical devices company, Sky Medical Technology Ltd, received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the geko™ device for increasing microcirculatory blood flow in lower limb soft tissue of patients with venous insufficiency and/or ischemia.

Read more: Monash University Researchers Develop Wearable Blood Pressure Monitor

The geko device is the first electrical neuromuscular stimulator of its kind to be cleared for increasing microcirculatory blood flow and adds to Sky's prior FDA clearances for edema reduction and for stimulation of the calf muscles to prevent venous thrombosis (blood clots) in both surgical and non-surgical patients.

Venous insufficiency and ischemia relate to reduced blood flow in the veins and arteries. This can lead to lower extremity edema, skin changes, and discomfort. Venous insufficiency can progress to chronic venous insufficiency (CVI), a serious condition attributed to diminished quality of life and loss of work productivity. In most cases, the cause is incompetent valves. Each year approximately 150,000 new patients are diagnosed with chronic venous insufficiency, and nearly $500 million is used in the care of these patients. If venous insufficiency and ischemia are left untreated, progressive CVI can lead to post-phlebitic syndrome and venous leg ulcers, the company said in a press release.

Three recently published studies, two led by Das, and the other led by Bosanquet demonstrate geko device-generated microcirculatory blood flow increase in the lower limbs of patients with venous insufficiency and ischemia. Both studies measured the increase using Laser Speckle Contrast Imaging, a non-invasive technique that measures blood flow.

CEO and Founder Bernard Ross said, "Achieving this latest 510(k) clearance is a significant milestone for Sky that will allow us to initiate a controlled market release of the geko device, to address venous insufficiency and ischemia in the first instance – a therapy area sorely in need of innovation. With this 510(k) and in partnership with leading US clinicians we can now press ahead to redefine the way vascular-related conditions can be treated."

The geko device is a non-invasive, easy-to-use, wearable therapy device. The size of a wristwatch and worn at the knee, the disposable device gently stimulates the common peroneal nerve activating the calf and foot muscle pumps, resulting in increased blood flow in the deep veins of the calf, at a rate equal to 60%6 of walking without a patient having to move. The device operates without external pressure to the leg and allows complete mobility.

Read more: This “Smart Stent” Can Monitor Blood Flow and Detect Narrowing of Artery

The company is headquartered in the UK and backed by leading international investors in both healthcare and technology. The company is in the process of submitting further FDA 510(k) applications to expand its claims related to blood flow increase to address venous insufficiency.

About Sky Medical Technology Ltd and Firstkind Ltd

Sky Medical Technology, the parent of Firstkind Ltd, is a UK-based medical devices company. Through its innovative mechanism of non-invasive neuromuscular electrostimulation, Sky has developed a ground-breaking NMES technology platform, OnPulse, embedded in its industry-leading product, the geko device. The company develops a range of products tailored to the needs of different medical application areas, selling both direct and through strategic partnerships or distributors in each major clinical area. Clinical areas of interest include DVT prevention, the treatment and reduction of edema, and venous insufficiency. The goal in each pathway is to partner with healthcare professionals to improve clinical outcomes and patient care whilst saving health system resources.

World famous Metaverse builder MetaEstate officially promulgated integrated planning of Satoshi island in Cryptovoxels metaverse. According to the plan, the island shall be divided into four areas by two central axis lines in Satoshi island as split lines, thus building high-end residences, a fund town, leisure and entertainment, and an art town. Based on the increasing market demand for Metaverse, MetaEstate will reasonably regulate land use, build premium architecture, introduce prestigious IP, exploit usage scenarios, implement marketing promotion, and so on to activate and enrich four areas, therefore forging Satoshi island into one of "Digital Utopia" series towns.

Read more: Will Combined Power of 5G and Artificial Intelligence Change Tech Innovations of Tomorrow?

In the world of Cryptovoxels, Satoshi island is located on the northwest side of Origin City, with its axis 700W, 350N in the center, whose island is 33658 square meters and owns 357 plots. The data from k1ic.com shows that the average land price of Satoshi island has reached 0.0194 ETH/㎡, ranking top among average prices in Cryptovoxels. Moreover, the total value of Satoshi island has as well reached 653.9 ETH, following Origin City. These figures prove Satoshi island in the Cryptovoxels world is the most sought-after and most heated-bidding area. Up to now, enterprises and institutions like RocketDollar, Cryptomeria Captial, Waterdrip Capital, Deeper Network, CryptoArt.Ai, and so on have already settled down in Satoshi island.

Integrated planning of Satoshi island

The northwest area of Satoshi island belongs to the high-end residence, having been built with high-end villas including Jupiter, Mercury, Venus, Mars, and Saturn. In the future, MetaEstate shall construct more smart living housing of Metaverse and related living facilities architecture, ingenious design, or architectural aesthetics leading the Metaverse world.

The southwest area of Satoshi island belongs to the fund town and its headquarters. Various famous funds and institutions have been introduced to settle in like RocketDollar, Cryptomeria Captial, Cryptogram Venture, Waterdrip Capital, Blueberry Labs HQ, NFT Lion Cubs, ME HQ, MerkleTree, and so on, this area is planned to become a well-known financial and enterprise block in Metaverse.

The northwest area of Satoshi island belongs to leisure and entertainment. So far this area has already constructed facilities including Street Art Social Club, Klay Ape Club, THE CROWD, with playing and leisure functions offered by this area. In the coming days, the buildings here will manifest the abstract imagination of the architects, more mutual and entertaining ways are waiting for explorers to experience them to their full extent.

The southeast area of Satoshi island belongs to an art town, with CLTR Gallery, Bored Mummy, METACHI Gallery, Ting Song Museum, and so on having settled in. In the future, there will be more and more galleries, exhibition halls, museums, and art sculptures to attract art lovers in the Metaverse to gather and create here.

"Digital Utopia" Plan

MetaEstate plans to forge Satoshi island into a comprehensive city among the whole Metaverse in the lead to meet all the demands of Satoshi residents and visitors. "Digital Utopia" series town including Satoshi island is a revolutionary experiment and has a profound influence on Metaverse's development.

As is known, later MetaEstate will officially promulgate the architectural planning of Miami island.

Read more: Apple Seeking to Boost Position in Augmented Reality Space, Buys AR Lens Startup

According to a report in August 2021, MetaEstate has bought in amounting to about 1.5 million dollars around 200 blocks in succession in Cryptovoxels Metaverse. Till now it increases its holding and is estimated to hold more than 400 blocks of Cryptovoxels Metaverse block. (According to statistics, the single address of Cryptovoxels Metaverse holding the number of Top 1 is only 169 blocks)

About MetaEstate

MetaEstate concentrates on offering Metaverse architecture service, absorbed in enriching content construction of Metaverse and thus reasonably regulating land use, building premium architecture, introducing prestigious IP, exploiting usage scenarios, implementing marketing promotion, and so on. Users can explore the Meteverse with the help of MetaEstate, including constructing all kinds of delicate architecture, customized wearable devices, and enjoying the service of property management.

Vayyar Imaging, the Israeli supplier of 4D imaging radar-based solutions, has teamed up with Amazon to make Vayyar Care, Vayyar's touchless fall detection solution, compatible with the new Alexa Together service from Amazon.

Read more: Cerna Home Care Releases “OnHand Assistance”, a Smartwatch for Seniors’ Safety

Wall-mounted sensors use point cloud imaging technology to constantly monitor their surroundings, providing peace of mind while respecting privacy. Vayyar Care detects falls in all lighting conditions, including pitch darkness, and even dense steam, making it ideal for use in bathrooms where 80% of falls happen and where customers may not want to have cameras.

After a fall, standard buttons and cords are often out of reach and even wearables cannot guarantee round-the-clock protection: a third of seniors forget to put on their devices, while a fifth refuse to use them, fearing loss of independence, a press release has said.

In fact, over 90% of seniors now prefer to continue to live independently rather than move into an assisted living community.

"We designed Alexa Together to help aging customers feel more comfortable and confident living independently," said Nicolas Maynard, Senior Manager of Amazon Alexa. "Alexa Together offers even more value for aging customers when they can connect a device like Vayyar Care. We're excited to team up with Vayyar Imaging to help give our customers added peace of mind.

When the Vayyar Care device detects a fall, it will send a signal to Alexa to ask if the customer wants to call the Alexa Together Urgent Response emergency helpline. Alexa will also send a notification to the aging loved one's caregiver.

"With today's seniors more empowered and engaged than ever, there's a clear need for smart technologies that enable them to maintain their lifestyles, providing the protection they demand and the peace of mind their families expect," said Raviv Melamed, Vayyar Co-founder and CEO. "That's exactly where Vayyar Care comes in, and I'm delighted that we're able to play a pivotal role in Amazon's new Alexa Together service."

Read more: Wearable Inertial Sensor-Based Devices Can Accurately Assess Elderly Fall Risk: Study

Vayyar Care builds on the global success of the company's B2B platform, which provides real-time fall detection and supports advanced activity analytics for senior living communities in the U.S., EU, China, Australia, and beyond.

The multifunctional sensing technology relies on low-power radio frequency waves, providing a safe, robust, and reliable solution for elderly people who want 24/7 protection without compromising their privacy or independence. Vayyar Care is available now from amazon.

Australian Telehealth firm Coviu said it will work on a project to create a new digital toolkit for telehealth wound care. The company is working in collaboration with the government research agency Commonwealth Scientific and Industrial Research Organization, the Western NSW Primary Health Network, university partners The University of Sydney and The University of Technology Sydney, and insurance firm Australian Unity.

Read more: Verizon BlueJeans Telehealth Integrates with Apple Health To Streamline Patient Care

The cost of chronic wounds is equivalent to more than $3.5 billion, approximately 2% of national healthcare expenditure, with more than 400,000 Australians estimated to suffer at any time.

The new suite of digital tools will provide a one-stop-shop for clinicians caring for wounds, which have become even more acute during the pandemic, especially in regional areas where there are workforce shortages.

Through AI-powered mobile imaging, physicians will be able to analyze and monitor wounds remotely.

Coviu has received roughly A$6.5 million ($4.5 million) in funding from the federal government's Medical Research Future Fund for this project, which will start development next year. Coviu targets to release its digital wound care toolkit on its platform in 2026, reports MobiHealthNews.

Commenting on the technology, Dr. Annie Banbury, Clinical Research Lead at Coviu said, “The wound care digital toolkit gives us an enormous opportunity to make a difference to the health and quality of life of aged care residents. It will support clinicians, such as GPs, to make data-informed clinical decisions for wound care during a telehealth video call. It will also allow more clinicians to provide high-quality wound care to residential aged care settings.  The toolkit will continue building Coviu’s AI digital tools to support health care providers”.

Read more: OCBC Bank Launches Healthcare App With Partners To Provide Access To Over 100 Telehealth Doctors

“The toolkit will bring together organizations with a range of expertise – from creating the AI solution with wound care experts to its implementation in residential aged care. For this project, we have Coviu, leading research institutions, aged care providers, and specialists in rural health and health economics. To have the backing of the Federal Government’s Medical Research Future Fund is fantastic – we can’t wait to get started.”

For years, the Oura Community has been sharing their patterns and following their body’s cycles manually with the help of their Oura Rings. Now, they have announced a new feature that helps to accurately track your period.

Though not available at launch, Oura users will also have access to educational content on topics like medication and sleep, workout heart rate recording, improved sleep-tracking accuracy, and blood oxygen (SpO2) monitoring during sleep. The educational content and workout heart rate features will be available later this year, and the sleep and blood oxygen tracking will come in 2022.

Read more: Oura, WHOOP, BioStrap and BioIntelliSense Invading Health Monitoring Space With Biometric Wearables

What’s Unique About Oura’s Approach?

Period Prediction Beta helps you track your period according to your body rather than your calendar. Because there are unique changes that occur in body temperature across the menstrual cycle, body temperature is the key biosignal used to accurately track, predict, and visualize your monthly cycle. During the menstrual cycle, body temperature tends to decrease during the first half (i.e., follicular phase). Ovulation, which typically takes place during the midpoint of your cycle and marks the transition from follicular to luteal, causes body temperature to sharply increase. Body temperature will usually remain elevated throughout the second half of the cycle (i.e., luteal phase). During menstruation, or your period, body temperature will decrease because of an estrogen surge that takes place, reports Oura.

Oura’s hardware capabilities enable precise and consistent measurement of body temperature, granting us the opportunity to capture your unique alternating patterns and reflect them back to you. Worn 24/7 on your finger, Oura enables a reliable digital diary for tracking and educating on your personal menstrual cycle patterns. Your Period Predictions from Oura are built from comprehensive data that builds over time, not single intakes.

All bodies are vastly different and menstrual cycles change not only from person to person but also from cycle to cycle. Women, especially, have many physiological changes that occur in their bodies over the course of a lifetime. Because Oura collects temperature data on a continuous basis, all cycle types—long, short, and highly variable—can be tracked and taken into account when making predictions for one unique person. Our personal body temperature patterns and cycles are intimately linked and highly variable for a reason; they’re tailored down to the individual level, which is why Period Prediction at Oura goes beyond taking the one-size-fits-all approach.

Read more: How Wearables Like Oura and Whoop Became Pandemic Lifestyle

How It Works

Oura predicts your period start date by tracking patterns in your natural body temperature variation over the course of your cycle. Keep in mind, you’ll need at least two months’ worth of consistent temperature data recorded in the Oura app for personal body temperature to be used in predictions. If you’re still in the process of accumulating your 60-day temperature baseline, or if your natural variation can't be detected due to contraceptive use or other hormonal changes, predictions will be based on your last period, cycle length, and regularity.

Zeit Medical, a Redwood City, CA-based startup that makes early warning systems for strokes during sleep, has raised $2 million in seed funding. The funding round was co-led by SeedtoB and Digilife, with participation from Y Combinator, Northsouth Ventures, Gaingels, Axial, Tamar Capital, Citta Capital, as well as angels Greg Badros, Theodore Rekatsinas, and a few others in the healthcare business.

The company said it will use the money to expand operations, build the team, and apply for FDA approval.

Read more: Ultrasound Wearable Patch Could Provide Early Warning for Heart Attacks and Strokes

“This funding will enable us to conduct our clinical studies and pursue FDA clearance,” said Orestis Vardoulis, Zeit Medical co-founder and CEO. “We’re excited to partner with SeedtoB Capital given their unique expertise in the clinical AI space and their shared belief in our vision to improve care and quality of life for anybody at risk for stroke.”

“Stroke remains a leading cause of death in the U.S., and millions of at-risk Americans fear experiencing a stroke when asleep or alone. The Zeit Medical team is tackling this issue with an innovative platform that will not only help improve outcomes but also the quality of life. We’re thrilled to partner with them on this journey,” said Ritesh Sharma, managing partner at SeedtoB Capital. Zeit’s wearable device is a soft headband with a lightweight electroencephalogram (EEG) in it. It works with a smartphone app to analyze brain activity and, using a machine learning model trained by human experts, watch for signs of an impending stroke.

Co-managing partner at Digilife Fund, Bobba Venkatadri, adds, “As science identifies ever more risk factors for stroke, breakthrough risk management options utilizing algorithms and AI have become of paramount importance. Zeit is at the forefront of a global effort to minimize preventable disability and suffering.” The device could be available as early as 2023.

Read more: MIT Researchers Develop Touch-Sensing Glove That May Help In Stroke Recovery

About Zeit Medical

Zeit Medical is an early-stage medical technology company combining the power of wearable sensors and AI to provide immediate at-home stroke detection. More than 90% of strokes in the U.S. go untreated each year, leading to lifelong disabilities and financial burdens for stroke survivors. Zeit Medical was founded by Orestis Vardoulis, a biomedical engineer and digital health expert, and Urs Naber, a critical care physician, after seeing the devastating effects strokes had upon their families. They began addressing this unmet clinical need during their Stanford Biodesign Innovation Fellowship. The company participated in the YCombinator S21 batch.

Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today the launch of its new wearable and continuous ambulatory blood pressure monitoring (ABPM) chest-monitoring device.

Read more: Biobeat Receives CE Mark for its Patch and Wristwatch for Vital Signs Monitoring

As blood pressure (BP) measurement has shown to be crucial in the early detection and prevention of clinical disorders, ABPM can act as a decisive indicator of patient health, tracking patient cardiac data continuously in real-life settings outside of the physician's office to provide an accurate, holistic and unbiased view of patient health. Biobeat's ABPM solution is currently the only cuffless ABPM application in the world; in addition to retaining patient comfort while enabling the continuation of an uninterrupted daily lifestyle, this solution revolutionizes the logistical workflow of the ABPM test, as each disposable, sterile monitor is delivered directly to the patient's home via courier.

"As healthcare continues its digital transformation, the use of ABPM technologies has become increasingly ubiquitous across the healthcare spectrum, and will continue its growth trajectory as we venture further into the post-COVID-19 era," said Arik Ben Ishay, CEO of Biobeat. "Biobeat is excited to support this positive trend with our new wearable ABPM solution, giving providers a continuous and accurate real-life view into patient cardiac health, replacing antiquated cuff-based technology."

Biobeat's disposable wearable chest monitor includes an easy and intuitive patient self-set-up, requiring no assistance from a clinician or technician. The device measures diastolic and systolic BP, as well as heart rate, mean arterial pressure, cardiac output, and systemic vascular resistance. Measurements are accessible via the patient's mobile phone via a designated app and are also readily available for physicians through an online report-analysis web application. By utilizing the wide range of vital signs measured by the Biobeat device, the report enables healthcare providers to gain a profound understanding of the root cause of the issues identified and truly personalize medicine, allowing for more precise prescription and titration of medications and therapies, says a press release.

The new product launch is supported by a recently published peer-reviewed clinical study. The study, which compared Biobeat's wearable wrist-monitoring device to a standard cuff-based ABPM device, found that Biobeat's device has ABPM monitoring capabilities comparable to the standard cuff-based ABPM device. Findings also demonstrated standard cuff-based ABPM devices resulted in higher blood pressure values, likely due to a startling effect resulting from the inflating cuff, and that Biobeat's wireless wrist monitor caused significantly less inconvenience compared to the cuff-based device. Additionally, the study demonstrated a 24-hour bias of -1.1 mmHg for both diastolic blood pressure (DBP) and systolic blood pressure (SBP), with a mean daytime bias of -1.9 mmHg for DBP and SBP, and an even smaller nighttime bias was determined.

Read more: Fitbit Wearables May Soon Start Measuring Your Blood Pressure

"In addition to systolic and diastolic BP, Biobeat's novel ABPM device measures cardiac output, stroke volume, heart rate, mean arterial pressure, and systemic vascular resistance, providing a comprehensive clinical understanding of an individual's health status," added Professor Arik Eisenkraft, MD, Chief Medical Officer of Biobeat. "This clinical study highlights the benefit of our device over commonly-used cuff-based ABPM devices, with a remarkable ease-of-use and lack of bias resulting from the mechanical effects of the inflating cuff."

Wearables may be able to detect flu even before a patient begins to show symptoms, according to a new study in JAMA.

The study, conducted by researchers at Duke University, showed that a wristband with biometric sensors could detect an influenza infection (H1N1). For the study, the team employed the Empatica E4 wristband, a medical-grade wearable device that measures heart rate, skin temperature, electrodermal activity, and movement in real-time.

Read more: Wearables Can Detect COVID-19 and Even Signs of Depression, Fitbit CEO Tells Axios

"Approximately 9% of the world is infected with influenza annually, resulting in 3 million to 5 million severe cases and 300 000 to 500 000 deaths per year. Adults are infected with approximately 4 to 6 common colds per year, and children are infected with approximately 6 to 8 common colds per year, with more than half of infections caused by human rhinoviruses (RVs),” the researchers wrote. “Given the highly infectious nature of respiratory viruses and their variable incubation periods, infections are often transmitted unwittingly in a manner that results in community spread, especially as no presymptomatic screening methods currently exist to identify respiratory viral diseases. With the increasing emergence of novel viruses, such as SARS-CoV-2, it is critical to quickly identify and isolate contagious carriers of a virus, including presymptomatic and asymptomatic individuals, at the population level to minimize the viral spread and associated severe health outcomes.”

In this study, the researchers recorded biometric data from young people before and after they were inoculated with H1N1 influenza and human rhinovirus.

In the first study, which involved 31 participants inoculated with influenza, Empatica's E4 wristband detected the difference between infection and non-infection with up to 92% accuracy. The second phase involved 18 participants inoculated with human rhinovirus, and here the E4 wristband detected the difference between infection and non-infection with 88% accuracy, reported principal investigator Jessilyn Dunn, Ph.D., of Duke University in Durham, North Carolina, and colleagues.

“This cohort study suggests that the use of a noninvasive, wrist-worn wearable device to predict an individual’s response to viral exposure prior to symptoms is feasible,” the authors of the study wrote. “Harnessing this technology would support early interventions to limit the presymptomatic spread of viral respiratory infections, which is timely in the era of COVID-19.”

Read more: Wearable Freeze-Dried Cell-Free Face Masks for COVID-19 Detection

“We hope to learn what sickness with COVID-19 looks like at the physiological level, and how parameters around heart rate, sleep, and movement change when a person gets infected,” explains Dunn. “We are also interested in comparing data from unvaccinated individuals, as well as people who develop breakthrough infections.”

Respira Labs, a leading respiratory healthcare tech company, has recently announced an AI-powered wearable lung monitor. The wearable could help with early diagnosis and management of chronic obstructive pulmonary disease (COPD), asthma, and COVID-19.

Read more: Noninvasive Wearable Sensors to Advance Chronic Respiratory Disease Management In Patients Around the World

The chest wearable Sylvee 1.0 is a complete, clinical-grade respiratory health wearable providing 2 weeks of non-stop monitoring.

“Well-established science shows that air trapping can be measured with more than 90% accuracy using low-frequency sound. There is a clear difference in the acoustic resonance spectra of COPD patients versus healthy controls,” explained Dr. Maria Artunduaga, Respira Lab’s founder and CEO. “With more than 100 million Americans affected by COPD, COVID-19, and asthma, and with an aging population, it can be lifesaving to remotely and accurately monitor lung function and discover a problem early enough to avoid serious consequences. Our goal is to flag abnormalities early, enable earlier treatment at home and empower patients to manage their own health.”

Sylvee monitors your pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature around the clock for 2-weeks to deliver actionable insights on how you can optimize your day-to-day respiratory health.

Since the pandemic, respiratory diseases have become the #1 cause of death in the U.S. and expenses. It's estimated that 10% of the world's population will be affected by a chronic respiratory disease by 2030.

Read more: S3 Connected Health Deploys Tool For Assessing COVID-19 Risk of Respiratory Deterioration

The standard of care today relies on heavily biased questionnaires and inaccurate pulse-oximeters, missing 50% of respiratory exacerbations leading to very expensive hospitalizations ($19,000 to $50,000) and early deaths (one out of two COPDers hospitalized today will die within the next two years), according to Repira Labs.

Respira's ground-breaking wearable patch uses audible sound to accurately measure trapped air.

Sylvee is named after Artunduaga’s grandmother, who suffered from COPD and died after symptoms quickly worsened without detection.

AMF Medical announced that its Sigi™ Insulin Management System, for diabetes treatment, has been granted Breakthrough Device Designation by the US Food and Drug Administration. Sigi is the only insulin patch pump for closed loop integration designed for use with standard, pre-filled pump cartridges.

Read more: Scientists Develop Ingestible Robot That Delivers Insulin Without The Need For External Needles

Sigi can be programmed to deliver basal and bolus insulin at both set and variable rates. In addition, as an Alternate Controller Enabled-pump, it is able to receive, execute and confirm dosing commands by interacting with Bluetooth-compatible, continuous glucose monitors and alternate controller devices, like a smartphone or an iController, the company said in a press release.

Sigi is also smaller, lighter, and more convenient than current insulin delivery systems. This is made possible by its ergonomic design, which accommodates standard, insulin pre-filled pump cartridges.

AMF Medical Co-CEO and Co-Founder Mr. Antoine Barraud said: “We would like to thank the FDA for recognizing our team's proprietary, patient-focused technology, which provides users with enhanced clinical and convenience features. This Breakthrough Device Designation will expedite the development of Sigi and prioritize its review in future FDA regulatory submissions. It is a huge step forward in bringing Sigi to market to improve insulin management.”

“Clinical study data has shown that Sigi is delightfully easy to use. Study patients have expressed satisfaction as well as eagerness for this next-generation patch to be readily available. We are pleased that the FDA also sees its clear value and is moving the process forward,” said Professor A. Wojtusciszyn, MD, Ph.D. from Lausanne University Hospital (CHUV) and principal investigator of the first Sigi clinical study.

Read more: Medtronic Launches Smart Insulin Pen with Real-Time CGM Data For People on Multiple Daily Injections

About AMF Medical

Originally founded in 2014 in the Swiss Medtech Valley, AMF Medical is developing a novel technology to address the unmet needs of people on insulin therapy. The company's flagship product, Sigi, is a next-generation, plug 'n go, semi-reusable, and rechargeable patch pump, designed to make life easier for people with diabetes. Sigi is intended for prescription use only and is not yet FDA Cleared nor CE-marked. AMF Medical is led by Co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, Ph.D. who is also a Co-Founder. Diabetes industry experts John Timberlake and Peter Gerhardsson serve on the company's Board of Directors.